Member Info for Magsy18

Another excellent point ST.

If you look back to the great week we had middle if September you can see that it was even more bullish back then according to your link. And as we know, since then the share price hasn't dipped AT ALL since then.

Magzy, can you point me to one of my posts which is unjustified given the current position of GDR?

I wouldn't believe I own 300k shares either, so you are right to dismiss it. Doing that also helps makes your point which is an advantage.

wise_buys

I refer you to....

Potential to reach over 300p in the next two weeks - low risk to reward - 28 Aug 2020 12:17

That's all.

Oh yeah, I guess another tiny difference is that NCYT also got a significant contract with the UK government which gave the company a large amount of publicity.

Other than that though, GDR and NCYT are exactly the same.

Yeah fair point ST. I guess the only small differences between GDR and NCYT were...

NCYT received WHO approval.
NCYT received FDA approval.
NCYT received a steady flow of significant sales.

Other than that, there was no reason why GDR should have behaved differently to NCYT.

Also keep in mind that £3 back then is equivalent to £1.85 now due to the dilution since.

This didn't seem to happen after their 16th July holding's RNS.

From one Magsy to another - increase your holding to 300,000 shares!

I don't know what is so hard to understand?

I can be positive about the future.
I can be negative about the current situation.
I can question the accuracy and justification of ramps (as I just did).
I can question the accuracy and justification of deramps (as I did the other day with DrM).

The above are not contradictory. Hopefully that clears things up for you.

I'm sorry but this post is embarrassing. Come on, even the positive people on this board have to call this one out?

You pluck the holdings RNS on the 24th April as the precursor for the rise that followed? You ignore the distribution agreement RNS release on the same day. You ignore the manufacturing milestone RNS that landed at the start of the rise and you ignore the WHO pre-qual RNS for the HCV test which pretty much everyone recognises was the trigger for the rise.

History often repeats itself huh? So after a short spike we should also see an down trend over an extended period of time? I suspect that history only repeats itself in the cases when the share price rises...

I believe that sales will happen at some point yes.

LTH14, I think you are missing the point here. I am counteracting the claim that because AVCT are higher than us without sales then we should at some point rise to meet them even if no significant news is released for GDR. Anybody claiming that after reviewing the months of evidence we have at our disposal is frankly just being intellectually dishonest.

If we start getting sales through then it's game on, that is the significant change that GDR needs to start it's climb. Once you have sales though it really is NCYT that you should be comparing against.

Don't take my word for it though, just look at what the market currently thinks and review it's thoughts over the last 5 months.

You have been making the same AVCT claim for months and months. You have been wrong for months and months. Still standing by the same argument after being so wrong for so long shows such an incredible lack of self awareness.

There is one entity more important than all of us that is also an 'AVCT denier' - the market.

You know the answers to my questions, you just can't bring yourself to answer them.

Cognitive Dissonance ahoy.

It's amusing to watch you squirm around, keep going son.

sorry, is not suddenly going to change.

When you have 5 months (or more) of empirical evidence of something being the case, it is pretty reasonable to assume that unless something changes significantly in relation to either company that the pattern is suddenly going to change.

You know that, you aren't stupid.

They prove that it can happen, it doesn't mean that it will happen. As usual you avoid answering the valid questions.

Again, why would the market suddenly put GDR on an 'equal' footing with AVCT without anything significantly changing?
Also, why are you making the assumption that it's GDR that are undervalued, rather than AVCT being overvalued.

You have been making the argument that AVCT has market cap of X without sales therefore GDR should rise. It hasn't. It won't.

If you want to compare, compare with NCYT which is where GDR strive to be.

When have GDR ever been on parity with AVCT? Why would GDR suddenly be on parity with AVCT without something significantly happening?

As I have said before, back in May/June, the people who were suggesting that the process of getting approvals/sales would take a good amount of time were denounced as derampers. The same sort of people who were doing this are now fine with the fact that it is taking a long time and some more desperate individuals try and convince themselves that taking a long time is actually a positive things because 'we need to get things right'.

DB himself didn't expect it to take this amount of time.

If there was sufficient buying pressure they wouldn't be able to control it.

It also takes a lot more time than David Budd, the CEO of our company, who has more expertise and knowledge around GDR than anyone on this board thinks.

Remember how confident he was of sales in June? Oops.

Sales have been landing very soon for 4 months.